Navigation Links
Voyance Announces Two-Year Contract Renewal for National Benchmarking Program with Physician Hospitals of America
Date:6/3/2013

Branford, CT (PRWEB) June 03, 2013

Voyance, healthcare’s leading provider of patient satisfaction, benchmarking, and perception management solutions, and PHA, the industry’s most credible advocate and resource center for physician owned hospitals, confirmed that they have signed a two-year contract renewal. Voyance has provided healthcare and technology leadership, serving as the clinical, operational, and financial benchmarking arm for PHA since 2008, and has recently completed data collection for the 20th consecutive quarter.

As PHA’s partner, Voyance electronically collects member feedback using innovative surveying techniques and real-time validation methods that ensure accurate and reliable data collection. This approach helps PHA’s members and PHA leadership have a true sense of hospital and census performance. The survey drills deeply into key performance measures tied to outcome of care, process of care, operational best practices and HCAHPS® performance. Finance looks at both drivers and results to arm hospital leadership with insight to opportunity.

“Voyance has enjoyed working with PHA these past five years and looks forward to continuing our partnership. PHA has excelled in every respect of process adherence, and through internal modeling, their nearly flawless adherence to SCIP protocol has helped this census preserve an extremely low presence of Surgical Site Infections (SSIs),” notes Paul Faraclas, President and CEO of Voyance. “It has been a privilege to work with this association and witness sustained excellence in numerous quality measurements since 2008.”

John Richardson, Executive Director at PHA, has been instrumental in creating '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry
2. AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards
3. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
4. University of Houston Graduate College of Social Work announces partnership with MD Anderson
5. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
6. AGA announces prestigious awards recognition recipients
7. TheBestHeartRateMonitorReviews.com Announces The Top 3 Heart Rate Monitors
8. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
9. Zane Benefits Announces Wellness HRAs: A New Way to Reward Healthy Employees
10. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
11. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... cells metastasize? Think of Sparta. , Ancient Greek warriors ... for the demands of battle on distant fields. Cancer ... to a new study revealing previously unknown differences between ... tumor site, and those that travel to other organs. ... metastasize is the primary cause of cancer-related death, understanding ...
(Date:9/21/2014)... 2014 Hundreds of Risperdal lawsuits ... Pennsylvania’s Philadelphia Court of Common Pleas, Bernstein Liebhard ... next monthly meeting has been scheduled for October ... “Our Firm is representing a number of plaintiffs ... We are pleased with its continued progress,” says ...
(Date:9/21/2014)... Best Cheap Hosting USA, one of the ... and GreenGeeks are the best Reseller hosting suppliers in ... hosting supplier. Actually, these companies have outperformed their competitors ... People can get the best web hosting at affordable ... to the manager, reseller hosting is a very popular ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 ... Fenofibrate (CAS 49562-28-9) Industry, 2009-2019 is a ... and Chinese Fenofibrate (CAS 49562-28-9) industry. The ... Fenofibrate (CAS 49562-28-9) including its classification, application ... and China’s top manufacturers of Fenofibrate (CAS ...
(Date:9/21/2014)... 21, 2014 More than 60 ... added over the past month to a federal ... cardiovascular injuries caused by the dialysis concentrate, Bernstein ... on September 15th shows 2,089 cases filed in ... Court, District of Massachusetts. These claims were filed ...
Breaking Medicine News(10 mins):Health News:Cancer cells adapt energy needs to spread illness to other organs 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 4Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4
... ... sugar and high in antioxidants. Summer is just around the corner so look and feel great ... the healthiest berry on earth! , ... York, NY (PRWEB) April 26, 2010 -- Move over acai, there’s a new berry in town ...
... degrees, for men with advanced disease, studies found, , ... this week of a therapeutic prostate cancer vaccine by ... milestone against the disease and cancer in general, experts ... survival in men with advanced prostate cancer, and it ...
... , ... at the recent 2010 DTC National Conference in Washington, D.C., agreed 2-1 that they would ... , ... Park, NJ (PRWEB) April 27, 2010 -- DTC Perspectives, Inc ., the leading conference, ...
... ... Exclusively at Target, with four all-natural treatment collections for all hair types and ethnicities. ... (PRWEB) April ... Care, which debuted exclusively in 233 Target stores on March 28, 2010. An ...
... ... their own custom branded mobile application to iPhone, iPad, and Android devices without having to ... ... its platform that allows businesses to build and deploy their own mobile application, ...
... ... to take place on May 6, 2010. Two years in the planning and development, ... center offers nonsurgical laser treatments for varicose veins and spider veins. , ... Prescott, AZ (PRWEB) April 27, 2010 -- Prescott ...
Cached Medicine News:Health News:Supercharge Summer with Superfood-infused Cookies! 2Health News:Supercharge Summer with Superfood-infused Cookies! 3Health News:Prostate Cancer Vaccine May Get FDA Approval 2Health News:Prostate Cancer Vaccine May Get FDA Approval 3Health News:Top DTC Marketers Choose Obama Over Romney and Palin 2Health News:Top DTC Marketers Choose Obama Over Romney and Palin 3Health News:Sundial Creations Announces the Debut of SheaMoisture Organic Hair Care Exclusively at Target 2Health News:Snowflake Mobile™ Launches Platform for Creating and Deploying Mobile Apps 2Health News:New Varicose Vein Treatment Center Opens in Prescott, Arizona 2
(Date:9/19/2014)... , Sept. 19, 2014 Today, iHealth Lab ... from Xiaomi Ventures, Ltd. for its first institutional round ... continue expanding iHealth,s global reach, accelerate growth and innovation, ... part of the investment, Xiaomi Ventures will join iHealth,s ... of cloud infrastructure and ecommerce. "We are ...
(Date:9/19/2014)... Kiromic, LLC, a Lubbock bio-pharmaceutical company, ... former chancellor of Texas Tech University, to its board as ... after raising $1.2 billion for the university. "Kiromic ... most successful chancellor in the history of Texas Tech University, ... but also as our new vice chairman of the board. ...
(Date:9/19/2014)... N.C. , Sept. 19, 2014  For ... cloud-based drug design and development, partnering is an ... mission is to design new drugs and identify ... 2 partners to further their development. The company ... investments. To support this business model, Cloud Pharmaceuticals ...
Breaking Medicine Technology:iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2
... Data in Pediatric Patients,Presented at the American ... N.J., Nov. 11 Daiichi Sankyo,Inc. (DSI), ... study supporting,the use of colesevelam HCl in ... presented for the first time at the,American ...
... 3.5 Fold Higher ... Compared to Standard Chemotherapy, SEATTLE, Nov. 11 ... it achieved the primary,efficacy endpoint of its phase III EXTEND ... non-Hodgkin,s,lymphoma (NHL) based on a preliminary intent to treat efficacy ...
Cached Medicine Technology:Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 2Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 3Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 4Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 5Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 6Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 7Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 2Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 3Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: